EP01.10: Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression
Back to course
Pdf Summary
Asset Subtitle
Luke Hoeppner
Powered By